A Study to Evaluate Efficacy of Ramosetron on Diarrhea-predominant Irritable Bowel Syndrome (IBS) in Male Patients
Clinical trial NCT01225237 · COMPLETED
Trial details
- NCT number
- NCT01225237
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2011-08-01
- Enrollment
- 296
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.